; (ii) facilitate interagency, multi-sectoral engagement to carry out GHSA implementation; (iii) provide a forum for raising and working to resolve interagency disagreements concerning the GHSA; (iv) review the progress toward, and work to resolve challenges in, achieving United States commitments under the GHSA, including commitments to assist other countries in achieving GHSA targets; (v) consider, among other issues— (I) the status of United States financial commitments to the GHSA in the context of commitments by other donors, and the contributions of partner countries to achieve GHSA targets; (II) the progress toward the milestones outlined in GHSA national plans for countries in which the United States Government has committed to assist in implementing the GHSA and in annual work plans outlining agency priorities for implementing the GHSA; and (III) the Joint External Evaluations of United States and partner country capabilities to address infectious disease threats, including the ability to achieve the targets outlined within the World Health Organization’s Joint External Evaluation tool, and gaps identified by such external evaluations; (vi) develop an annual report regarding the progress achieved, and the challenges faced, concerning the United States Government’s ability to advance GHSA across priority countries that— (I) includes recommendations to resolve, mitigate, or otherwise address the challenges identified in the report; and (II) is submitted to the President and to the appropriate congressional committees and is made publicly available; (vii) not later than September 1, 2020, complete a GHSA review that— (I) is submitted to the President and to the appropriate congressional committees; (II) includes an evaluation of the progress achieved during the 5-year period of the initiative, and any challenges faced in carrying out the initiative; and (III) includes recommendations on the future direction of the initiative